Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.
- DOI
- 10.1245/s10434-026-20318-8
- Published
- 2026-10-01
- Container
- Ann Surg Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1245/s10434-026-20318-8,
title = {Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.},
author = {Dottorini L and Viti M and Arru M and Senzani F and Petrelli F.},
year = {2026},
journal = {Ann Surg Oncol},
doi = {10.1245/s10434-026-20318-8},
url = {https://doi.org/10.1245/s10434-026-20318-8}
}RIS
TY - JOUR TI - Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026. AU - Dottorini L AU - Viti M AU - Arru M AU - Senzani F AU - Petrelli F. PY - 2026 JO - Ann Surg Oncol DO - 10.1245/s10434-026-20318-8 UR - https://doi.org/10.1245/s10434-026-20318-8 ER -
APA
L, D., M, V., M, A., F, S., & F., P. (2026). Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.. Ann Surg Oncol. https://doi.org/10.1245/s10434-026-20318-8
Source records
- europe-pmc · retrieved 2026-09-25T20:10:37.334Z